Intepirdine flops in phase 3 study of mild to moderate Alzheimer’s patientsNovember 28, 2017Alzheimer's & CognitionNeurologyGeriatrics
Development of a sigma 1 receptor agonist for Alzheimer’s proceeds based on 2-year phase 2 dataNovember 21, 2017Alzheimer's & CognitionNeurology
Schizophrenia’s silent epidemic: Iatrogenic sexual dysfunctionNovember 20, 2017Schizophrenia & Other Psychotic Disorders
Long-term cholinesterase inhibition may slow cognitive decline – and moreNovember 15, 2017Alzheimer's & CognitionNeurologyGeriatrics
Prenatal maternal anxiety linked to hyperactivity in offspring as teenagersNovember 15, 2017Anxiety Disorders
Pimavanserin found modestly effective in phase 2 Alzheimer’s psychosis studyNovember 14, 2017Alzheimer's & CognitionGeriatricsNeurology
Adjunctive minocycline for schizophrenia found beneficialNovember 9, 2017Schizophrenia & Other Psychotic Disorders
Amyloid imaging changed management for 80% of patients with uncertain dementia diagnosisNovember 9, 2017Alzheimer's & CognitionNeurologyGeriatrics
Use of opioids, SSRIs linked to increased fracture risk in RANovember 7, 2017PainAnxiety DisordersDepressionPain
Pediatric seclusion and restraint increases with ADHD, decreases with PTSDNovember 5, 2017PediatricsPTSDADHD
